"Dengue Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infection with DENGUE VIRUS. These include live-attenuated, subunit, DNA, and inactivated vaccines.
| Descriptor ID |
D053059
|
| MeSH Number(s) |
D20.215.894.899.162
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dengue Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Dengue Vaccines".
This graph shows the total number of publications written about "Dengue Vaccines" by people in this website by year, and whether "Dengue Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dengue Vaccines" by people in Profiles.
-
Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination. Cell Host Microbe. 2023 11 08; 31(11):1850-1865.e5.
-
Neutralization fingerprinting technology for characterizing polyclonal antibody responses to dengue vaccines. Cell Rep. 2022 12 13; 41(11):111807.
-
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021. MMWR Recomm Rep. 2021 12 17; 70(6):1-16.
-
Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies. Cell Host Microbe. 2020 05 13; 27(5):710-724.e7.
-
E. coli production process yields stable dengue 1 virus-sized particles (VSPs). Vaccine. 2020 04 09; 38(17):3305-3312.
-
Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. Vaccine. 2019 08 23; 37(36):5137-5146.
-
Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine. J Virol. 2018 12 01; 92(23).
-
Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes. Vaccine. 2019 07 26; 37(32):4601-4609.
-
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans. J Virol. 2017 12 15; 91(24).
-
Adult-onset, chronic, cyclic thrombocytopenia in a Rhesus macaque (Macaca mulatta) after dengue virus vaccination and viral challenge. Vet Clin Pathol. 2017 Jun; 46(2):238-247.